CD38 inhibition increases neuronal survival and reduces α-synuclein in vitro, elevates brain NAD(+), and reduces motor deficits in a Parkinson's disease model.
This newly indexed research record examines “CD38 inhibition increases neuronal survival and reduces α-synuclein in vitro, elevates brain NAD(+), and reduces motor deficits in a Parkinson's disease model.” Use the linked PubMed (NCBI) publication to assess the study design, population, methods, findings and limitations; an indexed record alone should not be read as clinical guidance.
Open original source ↗Collected Nov 8, 2026. Third-party data may change. Consult the original publication or registry for complete methods, findings and status.